{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:35:21Z","timestamp":1791297321150,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T00:00:00Z","timestamp":1539993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T00:00:00Z","timestamp":1539993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s13555-018-0266-x","type":"journal-article","created":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T08:16:10Z","timestamp":1540023370000},"page":"593-604","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Clinical and Genetic Risk Factors Associated with Psoriatic Arthritis among Patients with Psoriasis"],"prefix":"10.1007","volume":"8","author":[{"given":"Di","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Leslie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7883-6439","authenticated-orcid":false,"given":"Wilson","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,20]]},"reference":[{"issue":"10","key":"266_CR1","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1056\/NEJMra1505557","volume":"376","author":"CT Ritchlin","year":"2017","unstructured":"Ritchlin CT, Colbert RA, Gladman DD. Psoriatic arthritis. N Engl J Med. 2017;376(10):957\u201370.","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"266_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1468-3083.2009.03361.x","volume":"23","author":"G Girolomoni","year":"2009","unstructured":"Girolomoni G, Gisondi P. Psoriasis and systemic inflammation: underdiagnosed enthesopathy. J Eur Acad Dermatol Venereol. 2009;23[Suppl 1]:3\u20138.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"266_CR3","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1111\/jdv.13306","volume":"30","author":"N Betteridge","year":"2016","unstructured":"Betteridge N, Boehncke WH, Bundy C, Gossec L, Gratacos J, Augustin M. Promoting patient-centred care in psoriatic arthritis: a multidisciplinary European perspective on improving the patient experience. J Eur Acad Dermatol Venereol. 2016;30(4):576\u201385.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"266_CR4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s40744-016-0029-z","volume":"3","author":"A Kavanaugh","year":"2016","unstructured":"Kavanaugh A, Helliwell P, Ritchlin CT. Psoriatic arthritis and burden of disease: patient perspectives from the population-based multinational assessment of psoriasis and psoriatic arthritis (MAPP) survey. Rheumatol Ther. 2016;3(1):91\u2013102.","journal-title":"Rheumatol Ther"},{"issue":"6","key":"266_CR5","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1136\/annrheumdis-2013-204858","volume":"74","author":"M Haroon","year":"2015","unstructured":"Haroon M, Gallagher P, FitzGerald O. Diagnostic delay of more than 6\u00a0months contributes to poor radiographic and functional outcome in psoriatic arthritis. Ann Rheum Dis. 2015;74(6):1045\u201350.","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"266_CR6","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1038\/jid.2009.169","volume":"129","author":"KC Duffin","year":"2009","unstructured":"Duffin KC, Freeny IC, Schrodi SJ, et al. Association between IL13 polymorphisms and psoriatic arthritis is modified by smoking. J Invest Dermatol. 2009;129(12):2777\u201383.","journal-title":"J Invest Dermatol"},{"issue":"6","key":"266_CR7","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1136\/annrheumdis-2011-200416","volume":"71","author":"W Li","year":"2012","unstructured":"Li W, Han J, Qureshi AA. Smoking and risk of incident psoriatic arthritis in US women. Ann Rheum Dis. 2012;71(6):804\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"266_CR8","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1136\/ard.2010.147793","volume":"71","author":"L Eder","year":"2012","unstructured":"Eder L, Shanmugarajah S, Thavaneswaran A, et al. The association between smoking and the development of psoriatic arthritis among psoriasis patients. Ann Rheum Dis. 2012;71(2):219\u201324.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"266_CR9","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1001\/archdermatol.2010.141","volume":"146","author":"R Soltani-Arabshahi","year":"2010","unstructured":"Soltani-Arabshahi R, Wong B, Feng BJ, Goldgar DE, Duffin KC, Krueger GG. Obesity in early adulthood as a risk factor for psoriatic arthritis. Arch Dermatol. 2010;146(7):721\u20136.","journal-title":"Arch Dermatol"},{"issue":"6","key":"266_CR10","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1136\/ard.2006.064972","volume":"66","author":"PY Ho","year":"2007","unstructured":"Ho PY, Barton A, Worthington J, Thomson W, Silman AJ, Bruce IN. HLA-Cw6 and HLA-DRB1*07 together are associated with less severe joint disease in psoriatic arthritis. Ann Rheum Dis. 2007;66(6):807\u201311.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"266_CR11","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1001\/archdermatol.2010.136","volume":"146","author":"A Ogdie","year":"2010","unstructured":"Ogdie A, Gelfand JM. Identification of risk factors for psoriatic arthritis: scientific opportunity meets clinical need. Arch Dermatol. 2010;146(7):785\u20138.","journal-title":"Arch Dermatol"},{"issue":"2","key":"266_CR12","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/art.24172","volume":"61","author":"FC Wilson","year":"2009","unstructured":"Wilson FC, Icen M, Crowson CS, McEvoy MT, Gabriel SE, Kremers HM. Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study. Arthritis Rheum. 2009;61(2):233\u20139.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"266_CR13","doi-asserted-by":"publisher","first-page":"e1002877","DOI":"10.1371\/journal.pcbi.1002877","volume":"9","author":"A Dilthey","year":"2013","unstructured":"Dilthey A, Leslie S, Moutsianas L, et al. Multi-population classical HLA type imputation. PLoS Comput Biol. 2013;9(2):e1002877.","journal-title":"PLoS Comput Biol"},{"key":"266_CR14","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s13075-015-0640-3","volume":"17","author":"O FitzGerald","year":"2015","unstructured":"FitzGerald O, Haroon M, Giles JT, Winchester R. Concepts of pathogenesis in psoriatic arthritis: genotype determines clinical phenotype. Arthritis Res Ther. 2015;17:115.","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"266_CR15","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1002\/art.33415","volume":"64","author":"R Winchester","year":"2012","unstructured":"Winchester R, Minevich G, Steshenko V, et al. HLA associations reveal genetic heterogeneity in psoriatic arthritis and in the psoriasis phenotype. Arthritis Rheum. 2012;64(4):1134\u201344.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"266_CR16","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1136\/ard.2011.155044","volume":"71","author":"L Eder","year":"2012","unstructured":"Eder L, Chandran V, Pellet F, et al. Human leucocyte antigen risk alleles for psoriatic arthritis among patients with psoriasis. Ann Rheum Dis. 2012;71(1):50\u20135.","journal-title":"Ann Rheum Dis"},{"key":"266_CR17","unstructured":"Generalized additive models. London: Chapman and Hall; 1990."},{"key":"266_CR18","unstructured":"Prevention CfDCa. National Health and Nutrition Examination Survey: healthy weight, overweight, and obesity among U.S. adults; 2003. https:\/\/www.cdc.gov\/nchs\/data\/nhanes\/databriefs\/adultweight.pdf"},{"issue":"2","key":"266_CR19","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1046\/j.0022-202x.2001.01656.x","volume":"118","author":"JE Gudjonsson","year":"2002","unstructured":"Gudjonsson JE, Karason A, Antonsdottir AA, et al. HLA-Cw6-positive and HLA-Cw6-negative patients with Psoriasis vulgaris have distinct clinical features. J Invest Dermatol. 2002;118(2):362\u20135.","journal-title":"J Invest Dermatol"},{"issue":"4","key":"266_CR20","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/bjd.12473","volume":"169","author":"P Coto-Segura","year":"2013","unstructured":"Coto-Segura P, Eiris-Salvado N, Gonzalez-Lara L, et al. Psoriasis, psoriatic arthritis and type 2 diabetes mellitus: a systematic review and meta-analysis. Br J Dermatol. 2013;169(4):783\u201393.","journal-title":"Br J Dermatol"},{"issue":"2","key":"266_CR21","doi-asserted-by":"publisher","first-page":"315 e1","DOI":"10.1016\/j.jaad.2017.10.050","volume":"78","author":"MT Wan","year":"2018","unstructured":"Wan MT, Shin DB, Hubbard RA, Noe MH, Mehta NN, Gelfand JM. Psoriasis and the risk of diabetes: a prospective population-based cohort study. J Am Acad Dermatol. 2018;78(2):315 e1\u2013322 e1.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"266_CR22","doi-asserted-by":"publisher","first-page":"48","DOI":"10.5021\/ad.2017.29.1.48","volume":"29","author":"JW Choi","year":"2017","unstructured":"Choi JW, Kim BR, Seo E, Youn SW. Could psoriatic arthritis be easily diagnosed from current suspicious physical findings in the dermatology clinic? Ann Dermatol. 2017;29(1):48\u201354.","journal-title":"Ann Dermatol"},{"key":"266_CR23","unstructured":"Feingold KR, Grunfeld C. The effect of inflammation and infection on lipids and lipoproteins. In: De Groot LJ, Chrousos G, Dungan K, et al. (eds) Endotext. South Dartmouth: MDText.com, Inc.; 2000."},{"issue":"6","key":"266_CR24","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1002\/art.37916","volume":"65","author":"I Navarro-Millan","year":"2013","unstructured":"Navarro-Millan I, Charles-Schoeman C, Yang S, et al. Changes in lipoproteins associated with methotrexate or combination therapy in early rheumatoid arthritis: results from the treatment of early rheumatoid arthritis trial. Arthritis Rheum. 2013;65(6):1430\u20138.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"266_CR25","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s13075-016-1148-1","volume":"18","author":"S Hassan","year":"2016","unstructured":"Hassan S, Milman U, Feld J, et al. Effects of anti-TNF-alpha treatment on lipid profile in rheumatic diseases: an analytical cohort study. Arthritis Res Ther. 2016;18(1):261.","journal-title":"Arthritis Res Ther"},{"key":"266_CR26","first-page":"352686","volume":"2011","author":"KR Castro","year":"2011","unstructured":"Castro KR, Aikawa NE, Saad CG, et al. Infliximab induces increase in triglyceride levels in psoriatic arthritis patients. Clin Dev Immunol. 2011;2011:352686.","journal-title":"Clin Dev Immunol"},{"issue":"10","key":"266_CR27","first-page":"1997","volume":"34","author":"O Saiki","year":"2007","unstructured":"Saiki O, Takao R, Naruse Y, Kuhara M, Imai S, Uda H. Infliximab but not methotrexate induces extra-high levels of VLDL-triglyceride in patients with rheumatoid arthritis. J Rheumatol. 2007;34(10):1997\u20132004.","journal-title":"J Rheumatol"},{"issue":"3","key":"266_CR28","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1159\/000249936","volume":"165","author":"M David","year":"1982","unstructured":"David M, Abraham D, Weinberger A, Feuerman EJ. Generalised pustular psoriasis, psoriatic arthritis and nephrotic syndrome associated with systemic amyloidosis. Dermatologica. 1982;165(3):168\u201371.","journal-title":"Dermatologica"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-018-0266-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-018-0266-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-018-0266-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T11:31:08Z","timestamp":1724412668000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-018-0266-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,20]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["266"],"URL":"https:\/\/doi.org\/10.1007\/s13555-018-0266-x","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,20]]},"assertion":[{"value":"23 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2018","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}